Search - tctmd.com

Displaying 521 - 540 of 947

Sort: Relevancy | Date

Presentation TCT 2022

The CELT ACD® Large Bore (18F) Arterial Closure Device (Vasorum)

Presenter: Jim E. Coleman

September 18, 2022

Presentation TCT 2022

Modular Transcatheter Transseptal “ReValvable” Mitral Valve Replacement (ReValve): FIH Results

Presenter: Charles J. Davidson

September 18, 2022

Presentation TCT 2022

Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve

Presenter: Vinayak N. Bapat

September 18, 2022

Presentation TCT 2022

Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study

Presenter: Firas Zahr

September 18, 2022

Presentation TCT 2022

Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results

Presenter: Chet Rihal

September 18, 2022

Presentation TCT 2022

Trans-Apical Saturn TMVR System: 1-Year FIH Results (InnovHeart)

Presenter: Paolo Denti

September 18, 2022

Presentation TCT 2022

The Opus VR Valve: A Novel TMVR Tethered to the Ventricular Septum (Opus Medical)

Presenter: Vivek Rajagopal

September 18, 2022

Presentation TCT 2022

Choice of Optimal Transcatheter Treatment for Mitral Insufficiency: 2-Year Real-World Outcomes in the CHOICE MI International Registry

Presenter: Sebastian Ludwig

September 18, 2022

Presentation TCT 2022

Chordal Replacement and Annuloplasty in One Device With a Leaflet-Independent Procedure for DMR (Vesalius)

Presenter: Peter Skarsgard

September 18, 2022

News Conference News TCT 2022

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Michael O'Riordan

September 18, 2022

Presentation TCT 2022

Mitral Butterfly: An Upgrade in Transcatheter Mitral Repair (AVVie)

Presenter: Mathew Williams

September 18, 2022

Presentation TCT 2022

Dragonfly Mitral TEER Study From China: Technology and Early Feasibility Study Results

Presenter: D. Scott Lim

September 18, 2022

Presentation TCT 2022

1-Year Results of a Multicenter Trial of TEER With ValveClamp System in High-Risk Patients With DM

Presenter: Hasan Jilaihawi

September 18, 2022

Presentation TCT 2022

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

Presenter: Reda Ibrahim

September 18, 2022

News Conference News TCT 2022

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Ongoing Clinical Trials and the Future of LAAC

Presenter: Matthew Price

September 18, 2022

Presentation TCT 2022

Recent Clinical Trials & Registries: Update 2022

Presenter: Kolja Sievert

September 18, 2022

Presentation TCT 2022

Excluding the Infarcted LV Apical Segment of the Heart: The Bioventrix Device and Pivotal Study

Presenter: Rishi Puri

September 18, 2022

News Conference News TCT 2022

FLASH: More Data to Support Mechanical Thrombectomy in PE

L.A. McKeown

September 18, 2022

Presentation TCT 2022

Bringing Mitral Technologies to the Right: Key Physiological and Hemodynamic Differences

Presenter: Ajit P. Yoganathan

September 17, 2022

Advertisement

The CELT ACD® Large Bore (18F) Arterial Closure Device (Vasorum)

Modular Transcatheter Transseptal “ReValvable” Mitral Valve Replacement (ReValve): FIH Results

Outcomes of Mitral Regurgitation Patients Screen Failed for LVOT Obstruction Treated Using Altavalve

Transfemoral TMVR: Intermediate-Term Outcomes From the Intrepid Early Feasibility Study

Central Wrapping Concept for TMVR (Innovalve): Device Description and Early Clinical Results

Trans-Apical Saturn TMVR System: 1-Year FIH Results (InnovHeart)

The Opus VR Valve: A Novel TMVR Tethered to the Ventricular Septum (Opus Medical)

Choice of Optimal Transcatheter Treatment for Mitral Insufficiency: 2-Year Real-World Outcomes in the CHOICE MI International Registry

Chordal Replacement and Annuloplasty in One Device With a Leaflet-Independent Procedure for DMR (Vesalius)

As Time Goes By, Post-TAVI Thrombus Becomes More OAC Resistant

Mitral Butterfly: An Upgrade in Transcatheter Mitral Repair (AVVie)

Dragonfly Mitral TEER Study From China: Technology and Early Feasibility Study Results

1-Year Results of a Multicenter Trial of TEER With ValveClamp System in High-Risk Patients With DM

Current FDA-Approved Devices: How to Select; Lesion-Specific Differences

To Cure What Ails US Healthcare: Creativity, Value, Fairness, Says FDA’s Califf

Ongoing Clinical Trials and the Future of LAAC

Recent Clinical Trials & Registries: Update 2022

Excluding the Infarcted LV Apical Segment of the Heart: The Bioventrix Device and Pivotal Study

FLASH: More Data to Support Mechanical Thrombectomy in PE

Bringing Mitral Technologies to the Right: Key Physiological and Hemodynamic Differences

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content